![N-(2-Amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]benzamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F311647-n-2-amino-5-fluorophenyl-4-1-oxo-3-3-pyridinyl-2-propen-1-yl-amino-methyl-benzamide.webp&w=3840&q=75)
CAS 743420-02-2: N-(2-Amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]benzamide
Formula:C22H19FN4O2
InChI:InChI=1S/C22H19FN4O2/c23-18-8-9-19(24)20(12-18)27-22(29)17-6-3-16(4-7-17)14-26-21(28)10-5-15-2-1-11-25-13-15/h1-13H,14,24H2,(H,26,28)(H,27,29)
InChI key:InChIKey=WXHHICFWKXDFOW-UHFFFAOYSA-N
SMILES:N(C(=O)C1=CC=C(CNC(C=CC=2C=CC=NC2)=O)C=C1)C3=C(N)C=CC(F)=C3
Synonyms:- Benzamide, N-(2-amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propenyl]amino]methyl]-
- N-(2-Amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]benzamide
- Benzamide, N-(2-amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]-
Sort by
Found 6 products.
De-4-fluoro 5-Fluoro Chidamide
CAS:Applications De-5-fluoro 4-Fluorochidamide is an analogue of Chidamide (CAS 743420-02-0), a hitsone deacetylase inhibitor (HDACI) that enhances gemcitabine (G305000) cytotoxicity in pancreatic cancer cells. References Qiao, Z., et. al.: Biochem. Bioph. Res. Co., 434, 95 (2013)Formula:C22H19FN4O2Color and Shape:Off White PowderMolecular weight:390.41HDAC-IN-7
CAS:HDAC-IN-7 (HBI-8000) (Chidamide impurity) is an impurity of Chidamide.Formula:C22H19FN4O2Purity:97.86% - 98.45%Color and Shape:SolidMolecular weight:390.41Ref: TM-T2025
1mg62.00€2mg87.00€5mg137.00€10mg227.00€25mg454.00€50mg663.00€100mg944.00€1mL*10mM (DMSO)117.00€Chidamide
CAS:Chidamide is a nonsteroidal anti-inflammatory drug that inhibits the activity of histone deacetylase enzymes. It has been shown to inhibit the growth of cancer cells, including lymphoma and leukemia. Chidamide also has significant cytotoxicity against human cell lines in vitro, with minimal toxicity in vivo. Chidamide's anti-cancer effects are mediated through inhibition of histone deacetylase enzymes and induction of apoptosis. This drug may be a promising candidate for treatment of cancers with high levels of histone deacetylase activity such as lymphoma and leukemia.Formula:C22H19FN4O2Purity:Min. 95%Molecular weight:390.41 g/mol